Literature DB >> 1464423

From antilymphocyte serum to therapeutic monoclonal antibodies: first experiences with a chimeric CD4 antibody in the treatment of autoimmune disease.

G Riethmüller1, E P Rieber, S Kiefersauer, J Prinz, P van der Lubbe, B Meiser, F Breedveld, J Eisenburg, K Krüger, K Deusch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1464423     DOI： 10.1111/j.1600-065x.1992.tb01420.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN： 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  6 in total

1.  Elevated major histocompatibility complex class I expression protects T cells from antibody- and macrophage-mediated deletion.

Authors:  T Orlikowsky; Z Wang; A Dudhane; R Mittler; V Trejo; G E Dannecker; D Niethammer; M K Hoffmann
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

2.  Differential functional effects of a humanized anti-CD4 antibody on resting and activated human T cells.

Authors:  S J Brett; W Rowan; M Smith; M Bartholomew; J P Tite
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

3.  Functional analysis of the effects of a fully humanized anti-CD4 antibody on resting and activated human T cells.

Authors:  M Bartholomew; S Brett; K Barber; C Rossman; S Crowe; J Tite
Journal:  Immunology       Date:  1995-05       Impact factor: 7.397

Review 4.  New methods of treatment in an experimental murine model of systemic lupus erythematosus induced by idiotypic manipulation.

Authors:  Y Shoenfeld; I Krause; M Blank
Journal:  Ann Rheum Dis       Date:  1997-01       Impact factor: 19.103

5.  Repopulation of blood lymphocyte sub-populations in rheumatoid arthritis patients treated with the depleting humanized monoclonal antibody, CAMPATH-1H.

Authors:  S Brett; G Baxter; H Cooper; J M Johnston; J Tite; N Rapson
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

6.  Fas (CD95) expression and death-mediating function are induced by CD4 cross-linking on CD4+ T cells.

Authors:  J Desbarats; J H Freed; P A Campbell; M K Newell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.